Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-545-4 | CAS number: 7631-86-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity oral
For acute oral toxicity assessment, the data base compiles 20 studies performed between 1951 and 1999. They used test materials of Synthetic Amorphous Silica produced by different processes including pyrogenic, precipitated, gel and colloidal silica with specific surface area (BET) ranging from 45 to 420 m²/g. 5 of these studies meet the criteria for Klimisch score 1 and 15 studies met the criteria for Klimisch score 2 performed according to OECD guidelines 401, 420 or 423 or similar in either rats or mice. Mortality or significant toxicity were absent in all these studies. LD50 values exceeded the top doses tested.
LD50 values of >2000 mg/kg bw or >5000 mg/kg bw have thereby been established.
Acute toxicity inhalation:
For the acute inhalation toxicity assessment of untreated SAS, 6 studies performed between 1972 and 1983 are available and a new one recently conducted in 2019. Different forms of untreated SAS were tested with the specific surface (BET) ranging from 170-420 m2/g. In this long time period of absence of effects only in one study from 1977 one of ten animals died. But this study was unsuitable for the determination of acute inhalation systemic toxicity of inert and non-toxic SAS particles. The majority of the studies were conducted before the release of OECD guideline 403 (1981). Different test set-ups, not comparable, were used, i.e. most studies used the whole-body exposure, while nose-only has now become the preferred route of exposure. The results were recently confirmed by the latest study with a precipitated SAS according to OECD 436 which is the only one achieved a characterized aerosol of 5 mg/L and resulted in a LD50 > 5.01 mg/L air (Vivotecnia, 2019).
All early/former studies have technical deficiencies and do not entirely fulfill the criteria laid down in OECD 403. Due to the limited particle size information and the expected agglomeration of the tested SAS forms after atmosphere generation in the test chamber, the real exposure conditions of the animals in the older tests was not verified. Only one of these studies (Toxicogenics Inc., 1981) fulfills the technical conditions of OECD 403 in a sufficient way to justify a Klimisch rating of 2.
No mortality or significant toxicity was observed in 6 of the 7 studies (only 1 over 10 animal dead in a single study). For all these studies LC50 values are above the maximum achievable concentration or the highest concentration tested. The achievable test concentrations varied over 3 orders of magnitude (>0.139 mg/L and >207 mg/L) and based on the limited data available it is not possible to conclude on any reason for these differences. Maximum concentrations required by guideline were in the past not achievable due to technical limitations and possibly materials properties. However, the recent study (30 years later than the previous one) demonstrated the absence of mortality even under a stable 5 mg/L characterized aerosol, as confirmed by particle size distribution measurements.
Acute toxicity dermal:
The assessment of acute dermal toxicity for Set 1 is based on 5 studies performed in 1976 and 2000. Different forms of synthetic amorphous silica with specific surface area (BET) ranging from 115-349 m2/g were used as test materials.
These studies meet the criteria for Klimisch score 2 and were performed according to a protocol comparable to the OECD guideline 402, with certain restrictions. In 4 studies, 4 doses have been tested (2000, 3000, 4000, 5000 mg/kg bw) and the fifth study is a one dose (2000 mg/kg bw) study. Test material was applied once to intact and abraded skin for 24h. LD50 values exceeded the top doses tested. No mortality or significant toxicity were observed in any of the 5 studies.
LD50 values of >2000 mg/kg bodyweight have thereby been established and untreated SAS is therefore considered not toxic by dermal route.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- 3 dose l., single administration, 7d post obs.
- GLP compliance:
- no
- Specific details on test material used for the study:
- Cab-O-Sil (Fluffy)
- Species:
- rat
- Strain:
- other: doltzman albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- 117-159 g
food and water ad libitum, but withheld for 3-4 hours prior to dosage - Route of administration:
- other: stomach tube
- Vehicle:
- methylcellulose
- Doses:
- 1.00, 2.15, 3.16 g/kg/bw
- No. of animals per sex per dose:
- 5 (males only)
- Control animals:
- no
- Details on study design:
- 7 days post observation
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 3 160 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- no signs
- Body weight:
- body weight gain within the normal range
- Gross pathology:
- organs appeared within normal limits
- Conclusions:
- The acute oral LD50 of Cab-O-Sil (Fluffy) for male albino rats was greater than 3.16 g/kg/bw.
- Executive summary:
This badly documented study examined the LD50 of Cab-O-Sil (Fluffy). The substance is not described any further.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 12-26, 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 1987-02-24
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- fumed silica, M5 - OL, batch no.: 5E05 99A
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 98-116 g at the start of experiment, 6-7 weeks old, 7 days acclimatisation; from: Fredrick Institute, Padappai, India
12h light/dark, 5 animals of same sex per cage, standart pellet feed ad libitum, Aquaguard filtered water ad libitum - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- 5000 mg/kg/bw
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- single administration, 14 days of post administration observation
- Statistics:
- comparison of experimenta with control group using Student's t-test.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortaility
- Clinical signs:
- no clinical signs observed
- Body weight:
- on par with controls
- Gross pathology:
- no test substance related lesions
- Conclusions:
- The LD50 of Cab-O-Sil fumed silica for wistar rats was considered to be greater than 5,000 mg/kg/bw.
- Executive summary:
The experiment examined the oral LD50 of Cab-O-Sil fumed silica (M5).
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Jan. 14-28, 1988
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- experimental fumed silica, batch #SP 12-7033
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- obtained from: Charles River, Margate, Emgland;112-138 g, 4-6 weeks old, housed in groups by sex, 21-24 °C, mean humidity 59%, 12h light/dark; feed: Labsure LAD 1 and water ad libitum, except prior to administration and 4 hours thereafter
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Remarks:
- 25% w/v suspension in corn oil
- Details on oral exposure:
- adminsitered on two occasions, one hour apart
- Doses:
- 5 g/kg/bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- 14-day observation period
macroscopic post mortem on all animals - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- pilo-erection in all animals within 5 minutes after dosing and persisting throughout the day of dosing; no other clinical signs
- Body weight:
- slightly low bw gains for one male and two females in first week and one female in the second week of study
- Gross pathology:
- autopsy findings were normal
- Conclusions:
- As no mortality occured, the LD50 of experimental fumed silica was greater than 5 g/kg/bw.
- Executive summary:
The acute oral toxicity level of experiment fumed silica (SP 12-7033) was assessed in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Jun. - Sep. 1979
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- 1 dose level, single administration in the diet, 14-day observation period
- GLP compliance:
- not specified
- Limit test:
- yes
- Specific details on test material used for the study:
- Aerosil 130, Aerosil 150, Aerosil 200, Aerosil 300, Aerosil 380, Aerosil COK 84, Aerosil MOX 80, Aerosil MOX 170, Aerosil OX 50, Aerosil TT 600, Ultrasil VN 2, Ultrasil VN 3, Kieselsäure FK 160, Kieselsäure FK 300DS, Kieselsäure FK 310, Kieselsäure FK 320, Kieselsäure FK 320 DS, Kieselsäure FK 320 ZF, Kieselsäure FK 383 DS, Kieselsäure FK 700, Mattierungsmittel HK 125, Mattierungsmittel HK 400, Mattierungsmittel TS 100, Sident 3, Sipernat 22, Sipernat 30, Sipernat 42
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 116-328 g (males), 78-160 g (females), 5 per cage, 23 +/- 1 °C, tap water ad libitum
- Route of administration:
- oral: feed
- Vehicle:
- other: diet 1:4 (w/w)
- Doses:
- 10 g/kg bw
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- 14-day observation period
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil 130
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil 150
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil 200
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil 300
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil 380
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil COK 84
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil MOX 80
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil MOX 170
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil OX 50
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Aerosil TT 600
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Ultrasil VN 2
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Ultrasil VN 3
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Kieselsäure FK 160
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Kieselsäure FK 300DS
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Kieselsäure FK 310
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Kieselsäure FK 320
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Kieselsäure FK 320 DS
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Kieselsäure FK 320 ZF
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Kieselsäure FK 383 DS
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Kieselsäure FK 700
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Mattierungsmittel HK 125
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Mattierungsmittel HK 400
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Mattierungsmittel TS 100
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Sident 3
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Sipernat 22
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Sipernat 30
- Effect level:
- > 10 000 mg/kg bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Remarks:
- Sipernat 42
- Effect level:
- > 10 000 mg/kg bw
- Mortality:
- no mortality with any product
- Clinical signs:
- None of the tested products induced diarrhoea, changes in condition or behaviour or any other sign of toxicity. Stool changed colour to grey, but showed normal consistency with faecal pellets considerably bigger than normal.
- Gross pathology:
- Gross examination did not provide indications of treatment-related changes.
- Other findings:
- All but 3 animals, fed different products, consumed the supplemented diet quantitatively.
- Conclusions:
- It was concluded that the acute oral toxicity of all 27 tested products was greater than 10 g/kg bw, and probably even considerably higher.
- Executive summary:
The acute oral toxicities of 27 silicas were examined in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Aug. 16 - Sep. 4, 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 1987
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- yes
- Specific details on test material used for the study:
- Sident 9
- Species:
- rat
- Strain:
- other: WISW (SPFCpb)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- from: Winkelmann, Borchen, Germany; males: 9 weeks, 183-191 g; females: 10 weeks, 141-52 g; individually caged; feed: "ssniff R" and tap water ad libitum, except the last 16 hours before treatment; 20.5-22.5°C, 40-70% humidity, 12 h light/dark
- Route of administration:
- oral: gavage
- Vehicle:
- other: aqueous suspension stabilizied by 1% carboxymethylcellulose
- Doses:
- 5110 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- 14-day pbservation period
gross pathology performed on all animals - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 110 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 5 110 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- no signs of toxicity were recorded
- Body weight:
- All animals gained weight.
- Gross pathology:
- no alterations were detected
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortality occured, the LD50 value for male and female rats was greater than 5110 mg/kg bw.
- Executive summary:
The acute oral toxicty of Sident 9 was evaluated in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Nov. 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- single administration, 2 dose levels, 4-week post observation period
- GLP compliance:
- no
- Test type:
- standard acute method
- Specific details on test material used for the study:
- Sipernat 22
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: S. Ivanovas/Kißlegg, Germany
- Age at study initiation: 38 d (male), 42 d (female)
- Weight at study initiation: 100 - 105 g
- Fasting period before study: 15 - 16 h before start of the study
- Housing: single in Macrolon cages
- Water: ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24 +-0.5 °C
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
- Route of administration:
- oral: gavage
- Vehicle:
- other: water/methyl-hydoxyethyl cellulose 300 P (1%)
- Details on oral exposure:
- VEHICLE
- Justification for choice of vehicle: stabilisation of homogeneous distribution of light insoluble test material in aqueous gel suspension
MAXIMUM DOSE VOLUME APPLIED: yes (higher doses could not be produced)
- Doses:
- 2000 and 5000 mg/kg bw.
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 28 days
- Frequency of observations and weighing: data on days 1, 2, and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, food consumption mentioned - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- no particular findings
- Body weight:
- no significant findings
- Gross pathology:
- no particular findings
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortality occured the LD 50 was greater than 5000 mg/kg bw.
- Executive summary:
The acute oral toxicity of Sipernat 22 was assessed in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- 5 dose levels, single administration, 14-day post observation
- GLP compliance:
- no
- Specific details on test material used for the study:
- Syloid 378
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- obtained from: Charles River; males 160-230 g, females 126-180
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- distilled
- Doses:
- 464, 1000, 2150, 4640, 10000 mg/kg/bw
- No. of animals per sex per dose:
- 5
- Details on study design:
- 14-day observation period
Gross pathology performed on all animals which died or were scarified. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 8 810 mg/kg bw
- 95% CL:
- >= 5 449 - <= 14 224
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- ca. 7 376 mg/kg bw
- 95% CL:
- >= 5 210 - <= 10 443
- Mortality:
- males: 3/5 in highest dose group; no mortality in other groups
females: 4/5 in highest dose group; no mortality in other groups - Clinical signs:
- Decreased activity, ptosis, urine strains, involuntary muscle spasm, lacrimation, depression, prostration, irregular respiration, slight cyanosis and high carriage in highest dose groups. Normal appearance in other dose groups.
- Gross pathology:
- Gross pathology revealed no alterations to organs or tissues.
- Conclusions:
- The calculated LD50s were 8,810 and 7,376 mg/kg/bw for males and females, respectively.
- Executive summary:
The acute oral toxicity level of Syloid 378 was evaluated in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: E.U. directive 79/831
- Principles of method if other than guideline:
- 1 dose level, single administration, 14-day post observation
- GLP compliance:
- yes
- Specific details on test material used for the study:
- Tixosil 53
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- obtained from: Centre d'élevage d'IFFA CREDO, Saint-Germain sur l'Abresle; males 160-200 g, females 140-180 g, 6-7 weeks old, 5 per cage, feed: UAR AO4 and bottled water ad libitum, except during adminstration and preceeding 16-20 hrs., 22 +/-3 °C, 30 - 70 % humidity, 12 h light/dark
- Route of administration:
- oral: feed
- Vehicle:
- other: gum arabic
- Doses:
- 5000 mg/kg/bw
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Remarks:
- vehicle only
- Details on study design:
- 14-day post observation
necropsy performed on all animals - Preliminary study:
- yes, with 1000, 2500 and 5000 mg/kg/bw
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- no clinical signs
- Body weight:
- all animals gained body weight (slightly decreased in treated males)
- Gross pathology:
- no gross pathological changes
- Conclusions:
- As no mortality occured, the LD50 was greater 5000 mg/kg/bw.
- Executive summary:
The acute oral toxicity level of Tixosil 53 was assessed in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- single administration, 4 dose levels, 14-day post observation
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Zeo 49
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Remarks:
- SD/N BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- obtained from: Taconia Farm; 100-125 g, 5 per cage, Purina Laboratoty diet and water ad libitum
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- 33.3% suspension
- Doses:
- 10,000, 12,600, 15,800, 20,000 mg/kg bw.
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- 14-day observation period; daily observation for clinical signs and body weight; gross pathology performed
- Preliminary study:
- yes, with dose levels 1,000 - 20,000 mg/kg bw.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 20 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 20 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- Within 8 hours after dosing all animals exhibited white feces. Feces appeared normal by day 1.
- Body weight:
- All animals gained weight.
- Gross pathology:
- no abnormalities observed
- Conclusions:
- As no mortality occured the LD50 was greater than 20,000 mg/kg bw.
- Executive summary:
The acute oral toxicity of Zeo 49 was evaluated in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April/May 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- single administration, 4 dose levels, 14-day post observation
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Zeofree 153
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- SD/N BR rats weighing 100-125 grams were obtained from Taconic Farms, Inc..
The animals were housed up to five per cage and fed Purina Laboratory diet and water ad libitum. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- 20% suspension
- Doses:
- Based on the survival pattern in the range finding study, 5 male and 5 female rats were fasted for sixteen hours and gavaged at the following levels: 10,000, 12,600, 15,800, and 20,000 mg/kg of body weight.
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Animals were observed for reactions at 1, 2 and 4 hours after dosing and then daily for 14 days. Body weights were recorded at dosing and at termination. Rats dying or sacrificed were subjected to a gross examination of the viscera.
- Preliminary study:
- Following a one weeks acclimation to laboratory conditions, a series of range finding studies was conducted at dose levels of: 1000, 2000, 3000, 4000, 5000, 10,000, 20,000 mg/kg of body weight.
The rats were fasted approximately sixteen hours prior to receiving a single gavage of the test material. Dose range animals were observed up to 72 hours after dosing. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 20 000 mg/kg bw
- Mortality:
- Only one female of the highest dose group died.
- Clinical signs:
- Animal #8 on the 20,000 mg/kg dose level exhibited gasping immediately after dosing. On day 3 the animal was found dead.
Animals exhibited white feces diminishing by day 3. - Body weight:
- All surviving animals gained weight.
- Gross pathology:
- No abnormalities were observed in the surviving animals or the dead one.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As only one out of 10 animals of the highest dose group died, the LD50 was greater than 20,000mg/kg of body weight.
- Executive summary:
Zeofree 153 was evaluated for its oral LD50 in the rat.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April/May 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- single administration, 4 dose levels, 14-day post observation
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Zeosyl 113
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- SD/N BR rats weighing 100-125 grams were obtained from Taconic Farms, Inc..
The animals were housed up to five per cage and fed Purina Laboratory diet and water ad libitum. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- 33.3% suspension
- Doses:
- 10,000, 12,600, 15,800, 20,000 mg/kg bw.
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Animals were observed for reactions at 1, 2 and 4 hours after dosing and then daily for 14 days. Body weights were recorded at dosing and at termination. All rats were subjected to a gross examination of the viscera.
- Preliminary study:
- Following a one weeks acclimation to laboratory conditions, a series of range finding studies was conducted at dose levels of: 1000, 2000, 3000, 4000, 5000, 10,000, 20,000 mg/kg of body weight.
The rats were fasted approximately sixteen hours prior to receiving a single gavage of the test material. Dose range animals were observed up to 72 hours after dosing. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 20 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 20 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- Animals exhibited white feces beginning day 1, diminishing by day 2.
- Body weight:
- Animal at all levels gained weight.
- Gross pathology:
- Upon necropsy, on day 14, no abnormalities were observed.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortality occured , the LD50 was greater than 20,000 mg/kg of body weight.
- Executive summary:
Zeosyl 113 was evaluated for its oral LD50 in the rat.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- single administration, 4 dose levels, 14-day post observation
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- ZEOSYL® 200
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- SD/N BR rats weighing 100-125 grams were obtained from Taconic Farms, Inc..
The animals were housed up to five per cage and fed Purina Laboratory diet and water ad libitum. - Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- 15% suspension
- Doses:
- 10,000, 12,600, 15,800, 20,000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Animals were observed for reactions at 1, 2 and 4 hours after dosing and then daily for 14 days. Body weights were recorded at dosing and at termination. Rats dying or sacrificed were subjected to a gross examination of the viscera.
- Preliminary study:
- Following a one week acclimation to laboratory conditions, a series of range finding studies was conducted at dose levels of: 1000, 2000, 3000, 4000, 5000, 10,000, 20,000 mg/kg of body weight.
The rats were fasted approximately sixteen hours prior to receiving a single gavage of the test material. Dose range animals were observed up to 72 hours after dosing. - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 20 000 mg/kg bw
- Mortality:
- Only one female of the 12,600 mg/kg bw group died.
- Clinical signs:
- Animal exhibited white feces beginning day 1, diminishing by day 3.
- Body weight:
- All surviving animals gained weight.
- Gross pathology:
- Upon gross necropsy, on day 14, no abnormalities were observed in surviving animals. No abnormalities were observed upon necropsy of the dead female of the 12,600 mg/kg bw group.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortalty occured in the highest dose group, the LD50 was greater than 20,000 mg/kg of body weight.
- Executive summary:
Zeosyl 200 was evaluated for its oral LD50 in the rat.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Nov. 1977
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline available
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Specific details on test material used for the study:
- Aerosil 200
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: S. Ivanovas/Kißlegg, Germany
- Age at study initiation: 38 d (male), 42 d (female)
- Weight at study initiation: 100 - 105 g
- Fasting period before study: 15 - 16 h before start of the study
- Housing: single in Macrolon cages
- Water: ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24 +-0.5 °C
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
- Route of administration:
- oral: gavage
- Vehicle:
- other: water/methyl-hydoxyethyl cellulose 300 P (1%)
- Details on oral exposure:
- VEHICLE
- Justification for choice of vehicle: stabilisation of homogeneous distribution of light insoluble test material in aqueous gel suspension
MAXIMUM DOSE VOLUME APPLIED: no data
- Doses:
- 2000 and 3300 mg/kg bw. (higher concentrations could not be produced)
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 28 days
- Frequency of observations and weighing: data on days 1, 2, and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, food consumption mentioned - Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 3 300 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 3 300 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- no particular findings
- Body weight:
- slight reduction of 4 - 8 %, measured at days 1, 2, and 14
- Gross pathology:
- no particular findings
- Other findings:
- - Other observations: feed consumption reduced in the 2000-mg groups (10, 4 and 6 % at day 1, 2, and 14, respectively)
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortality occured the LD 50 was greater than 3300 mg/kg bw.
- Executive summary:
The acute oral toxicity of Aerosil 200 was evaluated in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- adm. by stomach tube, 6 dose l., single administration, 14d post obs.
- GLP compliance:
- no
- Specific details on test material used for the study:
- F-2 (fine white powder, faintly pungent)
- Species:
- mouse
- Strain:
- Swiss
- Remarks:
- albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- 18-26 grams, not fasted prior to dosing, food and water ad libitum
- Route of administration:
- other: stomach tube
- Vehicle:
- corn oil
- Doses:
- 178, 316, 562, 1000, 1780, 3160 mg/kg/bw
- No. of animals per sex per dose:
- 10 (males only)
- Control animals:
- no
- Details on study design:
- 14 d post observation
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 3 160 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- 2 deaths in 1000 mg/kg/bw group, but necropsy findings showed non-treatment-related causes
- Clinical signs:
- no signs
- Body weight:
- Overall (natural) weight gain
- Gross pathology:
- no findings
- Conclusions:
- The acute oral LD50 of F-2 for male albino Swiss mice was greater than 3160 mg/kg/bw.
- Executive summary:
A study with F-2 silica was carried out to determine its acute oral LD50 for mice.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EPA OPP 81-1 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- single dose level, triple administration within 2h , 24h post observation
- GLP compliance:
- no
- Specific details on test material used for the study:
- Cab-O-Sil EH-5
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- 4 males, 150-250 g, 6-10 weeks old, 12 h light/dark, 65-71 °F, 30-70 % humidity, housed in groups, Agway Prolab rodent feed and tap water ad libitum
- Route of administration:
- other: intragastric intubation
- Vehicle:
- water
- Details on oral exposure:
- 3 approximately equal doses separated by 1 h
- Doses:
- total: 5 g/kg/bw
- No. of animals per sex per dose:
- 4 (males only)
- Control animals:
- yes
- Details on study design:
- 24 h observation period
- Mortality:
- no mortality
- Clinical signs:
- no unusual findings
- Body weight:
- similar to control group
- Other findings:
- elevated levels of silica in urine (but might be due to contamination of urine with feces)
- Conclusions:
- no mortality, no clinical signs, but elevated levels of silica in urine
- Executive summary:
The acute oral toxicity potential of Cab-O-Sil EH-5 was evaluated in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- May 14-28, 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- 2/1987
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- yes
- Specific details on test material used for the study:
- Cab-O-Sil Fumed Silica M-5
- Species:
- mouse
- Strain:
- Swiss
- Remarks:
- albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 20-24 g, 7 weeks old, 12 h light/dark, housed in groups according to sex, standard pellet feed and Aquaguard filtered water ad libitum
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- destilled
- Doses:
- 5000 mg/kg/bw
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- 14 d post observation period
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- no clinical signs
- Body weight:
- no significant difference in body weight gain to control
- Gross pathology:
- no treatment related lesions
- Other findings:
- no mortality and no clinical signs in control group
- Conclusions:
- LD50 > 5000 mg/kg/bw
- Executive summary:
The acute oral LD50 of Cab-O-Sil (fumed silica) M-5 was examined in mice.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- 1 dose level, single administration, 14 d post observation
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- Cab-O-Sil (fumed silica) M-5
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- albino
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- individually caged, feed: Purina Certified Rodent Chow 5002, filtered tap water ad libitum, 12 h light/dark, 68-73 °F, 50-78 % humidity
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- deionized
- Details on oral exposure:
- dose administered in 2 portions approximately 4 h apart
- Doses:
- 5 g/kg/bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- 14-day post observation period
- Mortality:
- no mortality
- Clinical signs:
- One female exhibited gasping from 0 to 3 hours after administration of the first dose. One male exhibited moist rales on days 4 and 5.
No other clinical signs were observed. - Body weight:
- All animals gained weight during the study.
- Gross pathology:
- no abnormalities observed
- Conclusions:
- virtually no clinical signs (no secure relationship to test article in two mild cases), no abnormalities upon necropsy
- Executive summary:
An acute oral toxicity study with Cab-O-Sil M-5 was conducted in rats. No dose descriptor effect levels were evaluated.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- adm. by stomach tube, 6 dose l., single administration, 14d post obs.
- GLP compliance:
- no
- Specific details on test material used for the study:
- M-5 (fine white powder with no discernible odor)
- Species:
- mouse
- Strain:
- Swiss
- Remarks:
- albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- 18-26 grams, not fasted prior to dosing, food and water ad libitum
- Route of administration:
- other: stomach tube
- Vehicle:
- corn oil
- Doses:
- 178, 316, 562, 1000, 1780, 3160 mg/kg/bw
- No. of animals per sex per dose:
- 10 (males only)
- Control animals:
- no
- Details on study design:
- 14 days post observation
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 3 160 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- One death in 1000 mg/kg/bw group, but necropsy findings showed non-treatment-related effects.
- Clinical signs:
- no signs
- Body weight:
- overall (natural) weight gain
- Gross pathology:
- no findings
- Conclusions:
- The acute oral LD50 of M-5 for male albino Swiss mice was greater than 3160 mg/kg/bw.
- Executive summary:
A study with M-5 silica was carried out to determine its acute oral LD50 for mice.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Principles of method if other than guideline:
- n.a. (3 dose l., single administration, 4wk post obs.)
- GLP compliance:
- no
- Specific details on test material used for the study:
- TS 100 (also named: TK 100)
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 100 - 105g, 38 days-old males, 42 days-old females
- Route of administration:
- oral: gavage
- Vehicle:
- other: methyl hydroxyethylcellulose
- Doses:
- 3180, 4000, 5040 ml/kg/bw
- No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- post observation: 4 weeks; but LD50 determined after 24h and 7d
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 040 mL/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- no mortality
- Clinical signs:
- no indications of intolerance
- Body weight:
- slight drcrease in feed intak and body weight development, non-dose-depending
- Gross pathology:
- no specific findings
- Conclusions:
- LD50 > 5040 mg/kg/bw (after 24h and 7d)
- Executive summary:
The experiment investigated into the LD50 of TS 100 (also called TK 100 in the study) in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- 7 dose levels, single administration, 14-day post observation
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Ludox WP (colloidal silica)
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male
- Route of administration:
- other: intragastric intubation
- Vehicle:
- water
- Doses:
- 670, 2250, 3400, 5000, 7500, 11000, 17000 mg/kg/bw
- No. of animals per sex per dose:
- not specified
- Control animals:
- not specified
- Details on study design:
- sacrifice after 14-day post observation
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 17 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- no mortality
- Clinical signs:
- none
- Conclusions:
- The Approximate Lethal Dose (ALD) of Ludox WP was greater than 17,000 mg/kg/bw.
- Executive summary:
Ludox WP was administered by intragastric intubation to male rats. Only the summary page of this study was provided.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- July 1974
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- 1 dose level, single administration, 14-day post observation
- GLP compliance:
- no
- Specific details on test material used for the study:
- Syloid 244
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 5620 mg/kg (max. attainable dose)
- No. of animals per sex per dose:
- 30 (males only)
- Control animals:
- no
- Sex:
- male
- Dose descriptor:
- LD0
- Effect level:
- > 5 620 mg/kg bw
- Clinical signs:
- no symptoms of toxicity
whitish faeces - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LD50 after a 24-hour and 14-day observation period was greater 5.62 g/kg/bw.
- Executive summary:
The acute oral toxicity level of Syloid 244 was evaluated in rats.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Principles of method if other than guideline:
- Guidelines of the department of Transportation
1 dose level, 48-hour post observation - GLP compliance:
- not specified
- Specific details on test material used for the study:
- Syloid 244
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- oral: unspecified
- Doses:
- 31,600 mg/kg/bw
- No. of animals per sex per dose:
- 10 animals in total
- Details on study design:
- 48-hour post observation period
- Preliminary study:
- 2 rats each with 2,510, 3,980, 10,000 mg/kg/bw. No mortality occured.
- Dose descriptor:
- LD50
- Effect level:
- > 31 600 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Dose descriptor:
- LD0
- Effect level:
- >= 31 600 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- Animals were normal in appearance and behaviour.
- Gross pathology:
- Macroscopic changes were not observed in the viscera.
- Conclusions:
- As no mortality occured, the LD50 was greater 31,600 mg/kg/bw.
- Executive summary:
The acute oral toxicity of Syloid 244 was assessed in rats. This study is only badly documented since one page, presumably containing the study's method, is missing.
Referenceopen allclose all
No clinical symptoms; the stools were white coloured
(reversible after 2 days).
-----------------
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 21 - Oct. 4, 2019; experimental phase: May 21 - Jun. 5, 2019
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- First study of its kind reporting a characterized respirable aerosol of 5 mg/L for untreated SAS.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)
- Version / remarks:
- 9/2009
- Deviations:
- yes
- Remarks:
- MMAD slightly below recommended size; second GSD measurement above recommended value. None of the deviations was considered to have impact on the quality / integrity of the results or the study.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Specific details on test material used for the study:
- Zeosil Premium 200 MP, precipitated synthetic amorphous silica (SAS)
purity >= 98% - Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- obtained from: Envigo RMS Spain S.L., 08182 - Sant Feliú de Codines, Barcelona – Spain; 8 - 12 weeks old, 3 per cage, 12 h light / dark, 19.3 -23.9 °C, 30-66% humidity, food (Global diet 2914C) and tap water ad libitum except during exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- 0.975 µm
- Geometric standard deviation (GSD):
- ca. 1.42 - ca. 4
- Remark on MMAD/GSD:
- As the particle size was smaller than acceptance range, the aerosol could be considered as fully respirable.
The second Geometrical Standard deviation (GSD) measurement was 4.00 (first one: 1.42), slightly above criteria recommended by the OECD guideline Nº 436 (i.e. 1.5 - 3). Since the Mean Mass Median Aerodynamic Diameter (MMAD) was smaller than criterion for that measurement and a total of 90.91 % of the particles were ≤ 4 μm, the aerosol could be considered fully respirable. - Details on inhalation exposure:
- A dust aerosol was generated from the sieved test item using a Dust Generator SAG 410.
Inhalation exposure was performed using a flow-past, nose-only exposure system. The animals were confined separately in restraint tubes which were positioned radially around the exposure chamber. The exposure system ensured a uniform distribution and provided a constant flow of test material to each exposure tube. The mean flow of air at each tube was approximately 0.844 L/min, which was sufficient to minimize re-breathing of the test aerosol as it is more than twice the respiratory minute volume of rats. Exposure chambers type EC-FPC-232 (anodised aluminium, volume inside compartment: approximately 3 L), equipped with glass exposure tubes were used. The rats were individually exposed in glass tubes matching their size. Before treatment start, the homogeneity for the different levels of the exposure chamber was confirmed. The temperature and relative humidity of the test atmosphere in the exposure chamber were maintained as required by experimental conditions. Air flow was monitored regularly. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 5.01 mg/L
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- 14-day observation period
- Statistics:
- No statistical analysis was required.
- Preliminary study:
- none performed
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.01 mg/L air (analytical)
- Exp. duration:
- 4 h
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- >= 5.01 mg/L air (analytical)
- Exp. duration:
- 4 h
- Mortality:
- no mortality
- Clinical signs:
- other: Piloerection and wet fur were observed post-exposure in most animals. Piloerection lasted up to day 3 for animals ID1 (male) and ID6 (female). These signs are commonly associated to nose-only exposure studies and commonly observed in vehicle aerosols and/
- Body weight:
- A decrease in mean body weight was observed between study day 1 (exposure) and study day 2. This decrease is normally observed in nose-only exposure inhalation studies due to the stress caused by the restraining and the fasting conditions during the exposure period. In general, from study day 2 to the end of
the observation period (day 15), body weight increased gradually in all animals. - Gross pathology:
- No relevant macroscopic findings were observed in any of the animals.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LC50 of the test item was greater than 5.01 mg/L air (gravimetric aerosol concentration). Based on the GHS classification criteria, the test item can be considered as “unclassified”.
- Executive summary:
The present study has been designed to evaluate the acute inhalation toxicity of the test item ZEOSIL PREMIUM 200 MP in male and female Sprague Dawley rats by the acute toxic class (ATC) method (OECD test guideline Nº 436).
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- 18 April - 02 May 1983
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Remarks:
- The used method is unsuitable test system and the study was disregarded due to major methodological deficiencies
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- 1981-05-12
- Deviations:
- yes
- Remarks:
- The highest attainable exposure concentration was not applied due to technical limitations. Air exchange of the inhalation chamber was lower than recommended 0.8/h instead of 10 - 15/h.
- GLP compliance:
- yes
- Limit test:
- yes
- Specific details on test material used for the study:
- Aerosil 200
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Central Institute for Breeding of Laboratory Animals TNO, Zeist/NL
- Age at study initiation:
- Weight at study initiation: 191 - 199 g: av. 194 g (male); 144 - 149 g: av. 147 g (female)
- Fasting period before study: no
- Housing: single during exposure
- Diet: institute's stock diet ad libitum until start
- Water: tap water ad libitum until start
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +-1
- Humidity (%): 50 - 60
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
- Animals per cage: 5
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: stainless steel exposure chamber provided with glass windows
- Exposure chamber volume: 1.5 m3
- Method of holding animals in test chamber: single
- Source and rate of air: entrance near the pyramidal top; 1.2 m3/h ==> exchange rate = 0.8/hour
- Method of conditioning air: no data
- System of generating particulates/aerosols: Dispersing the powder continuously by means of a "Buerstendosierer" Typ III/A
- Method of particle size determination: cascade impactor
- Treatment of exhaust air: no data
- Temperature, humidity, pressure in air chamber: no data
TEST ATMOSPHERE
- Brief description of analytical method used:
gravimetrically - amount of dust on glass fiber filter divided by the amount of air applied (at 4 time point during exposure)
Nominal concentration calculated from the the total quantity of test material devided by the amount of air applied
- Samples taken from breathing zone: no data
TEST ATMOSPHERE
- Particle size distribution: approx. 47 - 50 mass% =< 6 µm
from Report Tab. 1:
distribution aerodynamic
in % of total weight diameter (µm)
----------------------------------------
4.7 0.47
6.0 0.7
7.2 1.1
6.6 1.7
2.2 2.5
4.2 3.4
6.4 4.3
9.9 5.7
52.7 >=7.7
_________________________________________
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): MMAD = ~3.2 µm / GSD: no data
Note: calculated from the VMD (Volume Mean Diameter) of 63.0 µm multiplied with the density of abouit 0.05 g/cm3.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting concentration: maximum attainable concentration - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- maximum technically attainable analytical concentration: av. 139 mg/m3 (range 110 - 190 mg/m3)
Nominal concentration: 16.7 g/m3 - No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: body weight on days 0, 2, 4, 7, and 14
- Necropsy of survivors performed: yes, on all
- Other examinations performed: clinical signs, body weight - Statistics:
- not relevant
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- >= 139 mg/m³ air (analytical)
- Exp. duration:
- 4 h
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 139 mg/m³ air (analytical)
- Exp. duration:
- 4 h
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Mortality:
- no mortality
- Clinical signs:
- other: Restlessness and half-closed eyes during exposure.
- Body weight:
- Both males and females showed growth retardation on the second day of the observation period.
However, by mistake the animals were deprived of drinking water during a period of 16 hours succeeding the termination of the exposure. Consequently food intake will have been very small during this period resulting in growth retardation. It is therefore impossible to indicate whether the growth retardation observed was an effect of the Aerosil 200 exposure or an effect of the water depriviation. - Gross pathology:
- no abnormalities found
- Other findings:
- none
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- From the results of the present acute inhalation study, it was concluded that an exposure of rats during 4 hours to the maximum attainable concentration of Aerosil 200 in the atmosphere (i.c. 139 mg/m3 air) failed to induce mortality.
- Executive summary:
The acute inhalative toxicity of Aerosil 200 could not be evaluated in rats maximum attainable concentration of Aerosil 200 in the atmosphere (i.c. 139 mg/m3 air) failed to induce mortality.
Whole body is not state of the art. Nowadays nose-only studies are applied for particle inhalation assessment. Unsuitable for the determination of acute inhalative systemic toxicity of inert /non-toxic SAS particles.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Remarks:
- The used method is unsuitable test system and the study was disregarded due to major methodological deficiencies
- Qualifier:
- according to guideline
- Guideline:
- other: Acute Inhalation Exposure in Rats: Federal Hazardous Substances Labeling Act
- Principles of method if other than guideline:
- single dose level, 1h administration, 14 d post observation
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Cab-O-Sil EH-5
- Species:
- rat
- Strain:
- not specified
- Remarks:
- albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- initially weighing between 200-300 grams
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- The test material was generated by means of a pulse-puff aerosol (powder) generator. A steady airstream maintained at 5 l/min carried the powder aerosol into the chamber.
- Duration of exposure:
- 1 h
- Concentrations:
- 207 mg/l
- No. of animals per sex per dose:
- 10 (males only)
- Control animals:
- no
- Details on study design:
- 14-day post observation period
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 207 mg/L air (nominal)
- Exp. duration:
- 1 h
- Mortality:
- no mortality
- Clinical signs:
- other: hypoactivity, increased respiratory rate, gasping, abdominal respiration, and exudates from the eyes, nose and mouth.
- Gross pathology:
- no necropsies performed
- Other findings:
- During the first two days of the postexposure period, all rats had dried brown material around the nose and mouth. The fur appeared chalky to the touch. However, these conditions subsequently disappeared and all rats appeared normal throughout the remainder of the 14-day postexposure observation period.
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Based on exposure some particle related clinical findings were observed but disappeared completely during recovery. No mortality was observed.
- Executive summary:
The objective of this study was to determine the inhalation toxicity in rats resulting from a one-hour, dynamic exposure to a predetermined concentration of a Cab-O-Sil EH-5.
No guideline followed. Only 1 hour exposure, only nominal concentrations reported, no exposure concentrations were determined.
Whole body is not state of the art. Nowadays nose-only studies are applied for particle inhalation assessment.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- Sep. 14-28, 1981
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1300 (Acute inhalation toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-3 (Acute inhalation toxicity)
- Principles of method if other than guideline:
- 1 dose level, 4h administration, 14d post observation
- GLP compliance:
- no
- Specific details on test material used for the study:
- Cab-O-Sil fumed silica M-5
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- albino
- Sex:
- male/female
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Mass median aerodynamic diameter (MMAD):
- 0.76 µm
- Geometric standard deviation (GSD):
- 3.11
- Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 2.08 mg/l
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- 14 d post obervation period
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 2.08 mg/L air (analytical)
- Exp. duration:
- 4 h
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- >= 2.08 mg/L air (analytical)
- Exp. duration:
- 4 h
- Mortality:
- no mortality
- Clinical signs:
- other: nasal discharge, crusty eyes, alopecia, crusty nose
- Body weight:
- animals exhibited body weight gains
- Gross pathology:
- no gross lesions, discoloration of the lung was observed in one test animal
- Other findings:
- no mortality, no clinical signs, normal body weight gain and normal pathological appearance in control group
- Conclusions:
- LC50 > 2.08 mg/l (no mortality with 2.08 mg/l)
- Executive summary:
The acute inhalation toxicity of Cab-O-Sil (fumed silica) M-5 was evaluated in rats.
Whole body is not state of the art. Nowadays nose-only studies are apllied for particle inhalation assessment.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Remarks:
- The used method is unsuitable test system and the study was disregarded due to major methodological deficiencies.
- Qualifier:
- according to guideline
- Guideline:
- other: Federal Hazardous Substances Labeling Act
- Principles of method if other than guideline:
- single dose level, 1h administration, 14 d post observation
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Cab-O-Sil M-5
- Species:
- rat
- Strain:
- not specified
- Remarks:
- albino
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- 200-300 g
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- The test material was generated by means of a pulse-puff aerosol (powder) generator. A steady airstream maintained at 5 l/min carried the powder aerosol into the chamber.
- Duration of exposure:
- 1 h
- Concentrations:
- 191.3 mg/l
- No. of animals per sex per dose:
- 10 (males only)
- Control animals:
- no
- Details on study design:
- 14-day post observation period
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 191.3 mg/L air (nominal)
- Exp. duration:
- 1 h
- Mortality:
- no mortality
- Clinical signs:
- other: hypoactivity, gasping, abdominal respiration, nasal exudation
- Gross pathology:
- no necropsies performed
- Other findings:
- During the first two days of the postexposure period, all rats had dried brown material around the nose and mouth. The fur appeared chalky to the touch. However, these conditions subsequently disappeared and all rats appeared normal throughout the remainder of the 14-day postexposure observation period.
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Based on exposure some particle related clinical findings were observed but disappeared completely during recovery. No mortality was observed.
- Executive summary:
The objective of this study was to determine the inhalation toxicity in rats resulting from a one-hour, dynamic exposure to a predetermined concentration of a Cab-O-Sil M-5.
No common guideline followed. Only 1 hour exposure, only nominal concentrations reported, no exposure concentrations were determined. Whole body is not state of the art. Nowadays nose-only studies are applied for particle inhalation assessment.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- 02 Feb. - 16 Feb. 1983
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Remarks:
- The used method is unsuitable test system and the study was disregarded due to major methodological deficiencies
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- The highest attainable exposure concentration was not applied due to technical limitations. Air exchange of the inhalation chamber was lower than recommended 0.8/h instead of 10 - 15/h.
- GLP compliance:
- yes
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Central Institute for Breeding of Laboratory Animals TNO, Zeist/NL
- Age at study initiation:
- Weight at study initiation: 168 - 179 g: av. 174 g (male); 142 - 146 g: av. 144 g (female)
- Fasting period before study: no
- Housing: single during exposure
- Diet: ad libitum until start
- Water: ad libitum until start
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +-1
- Humidity (%): 50 - 60
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose only
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: stainless steel exposure chamber provided with glass windows
- Exposure chamber volume: 1.5 m3
- Method of holding animals in test chamber: single
- Source and rate of air: entrance near the pyramidal top; 1.2 m3/hour ==> 0.8/h
- Method of conditioning air: no data
- System of generating particulates/aerosols: Dispersing the powder continuously by means of a "Buerstendosierer" Typ III/A
- Method of particle size determination: cascade impactor
- Treatment of exhaust air: no data
- Temperature, humidity, pressure in air chamber: no data
TEST ATMOSPHERE
- Brief description of analytical method used:
gravimetrically - amount of dust on glass fiber filter divided by the amount of air applied (at 4 time point during exposure)
Nominal concentration calculated from the the total quantity of test material devided by the amount of air applied
- Samples taken from breathing zone: no data
TEST ATMOSPHERE
- Particle size distribution: approx. 65 mass% =< 6 µm (note: 45 mass% with <5 µm are stated on p.6 of the report. This is not in agreement with the profile given in Table 1., see below.)
from Report Tab. 1:
distribution aerodynamic
in % of total weight diameter (µm)
----------------------------------------
1.8 0.47
2.8 0.7
4.3 1.1
5.0 1.7
8.1 2.5
9.4 3.4
14.3 4.3
19.2 5.7
35.1 >=7.7
_________________________________________
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): MMAD = ~0.6 µm / GSD: no data
Note: calculated from the VMD (Volume Mean Diameter) of 11.5 µm multiplied with the density of abouit 0.05 g/cm3.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting concentration: maximum attainable concentration - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- maximum attainable concentration: 691 mg/m3 (range: 650 - 725 mg/m3)
Nominal concentration: 36.7 g/m3 - No. of animals per sex per dose:
- 5
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: body weight on days 0, 2, 4, 7, and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- not relevant
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- >= 691 mg/m³ air (analytical)
- Exp. duration:
- 4 h
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 691 mg/m³ air (analytical)
- Exp. duration:
- 4 h
- Mortality:
- no mortality
- Clinical signs:
- other: Restlessness, half-closed eyes
- Body weight:
- males: normal; females: some delay until day 2, then normal
- Gross pathology:
- no particular findings
- Other findings:
- none
- Interpretation of results:
- other: non-toxic
- Conclusions:
- Exposure of rats for 4 hours to the maximum attainable concentration of Sipernat 22 S in the atmosphere (c. 691 mg/m³ air) did not result in any adverse effects: LC50 > 691 mg/m³
- Executive summary:
The acute inhalative toxicity of Sipernat 22 S could not be assessed in rats as the maximum attainable aerosol concentration in the chamber could not be reached. Unsuitable for the determination of acute inhalative systemic toxicity of inert /non-toxic SAS particles.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- significant methodological deficiencies
- Remarks:
- The used method is unsuitable test system and the study was disregarded due to major methodological deficiencies
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- 1 dose level, 1-hour administration, 14-day post observation
- GLP compliance:
- no
- Specific details on test material used for the study:
- synthetic amorphous silicon dioxide Syloid 244
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- obtained from: Charles River Breeding Laboratories, caged together, Purina cubed diet and tap water ad libitum
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Duration of exposure:
- 1 h
- Concentrations:
- 2 mg/l
- No. of animals per sex per dose:
- 10 (males only)
- Details on study design:
- 14-day observation period
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- > 2 mg/L air (nominal)
- Exp. duration:
- 1 h
- Mortality:
- 1/10 (animal died 2 hours post exposure)
- Clinical signs:
- other: During exposure signs of irritation and dyspnea were apparent in most animals.
- Body weight:
- normal body weight gain
- Gross pathology:
- slight to moderate incidences of pulmonary abnormalities when observed at necropsy at 14 days post esposure
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- As only 1 out of 10 animals died, the acute LC50 was greater than 2 mg/l.
- Executive summary:
The acute inhalative toxicities of 24 compounds were assessed in rats. One of them was synthetic amorphous silica Syloid 244 which is documented here.
No guideline followed. Only 1 hour exposure, only nominal concentrations reported, no exposure concentrations were determined. Unsuitable for the determination of acute inhalative systemic toxicity of inert /non-toxic SAS particles.
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 12.03.2020 - 06.07.2020
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Justification for type of information:
- A comprehensive method to test the bioactivity of respirable synthetic amorphous silica (SAS) in vitro is the alveolar macrophage assay, as offered by the IBE R&D gGmbH. Based on longstanding experience with primary alveolar macrophages (AMs) the assay circumvents the use of animals as it is carried out with cultured NR8383 macrophages (a cell line derived from rat lung). The relevance of the assay relies on the fact that lung alveolar macrophages are the first line of defense against inhaled (nano)materials, which they ingest and transport to the mucociliary escalator, to eventually clear the lung from inhaled foreign material. If the population of AMs is harmed, the lung epithelium will react with signs of inflammation. The predictivity of the alveolar macrophage assay for inflammatory effects of particles has best been demonstrated by Martin Wiemann and his group in a paper published in 2016 (J. Nanobiotechnology 14:16). In that paper the assay was compared to 19 inhalation studies (carried out by BASF under GLP conditions) and it was shown that the classification criteria matched what was found by BASF pathologists, as the assay was able to distinguish between active and passive (nano)materials. Up to now no other assay has been validated against a similarly high number of inhalation studies carried out with exactly the same (nano)materials. Due to these features the assay has been used in several national (NanoGEM, NanoGRAVUR, InnoMat.Life) and EU projects (NanoToxClass, Refine) and meanwhile is mentioned in many papers. Importantly, the assay has been suggested as a tool for grouping nanomaterials in a tiered approach as suggested by Wohlleben and the NanoGRAVUR consortium (2019). More specifically, and with respect to SAS analysis, the assay was successfully used to analyze the bioactivity of 14 different SAS including colloidal, fumed, precipitated, and gel qualities.
- Qualifier:
- no guideline required
- GLP compliance:
- no
- Test type:
- other: in vitro assay with alveolar macrophages
- Specific details on test material used for the study:
- untreated SAS:
AEROSIL® 50
CAB-O-SIL® (E)L-90
CAB-O-SIL® S17D
DAVISIL® XWP1500A
LUDOX® SM
LUDOX® TM-50
SIPERNAT® 350
SYLOID® AL-1FP
silanized SAS:
AEROSIL® R 504
AEROSIL® R 711
AEROSIL® R 816
CAB-O-SIL® TGC413TRD
CAB-O-SIL® TS610
CAB-O-SIL® TS720
HDK® H15
HDK® H2000
SIPERNAT® D 17 - Species:
- other: rat alveolar macrophage cell line NR8383
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- in vitro cell culture model
- Route of administration:
- other: in vitro cell culture model
- Type of inhalation exposure:
- other: in vitro cell culture model with alveolar macrophages
- Vehicle:
- other: cell culture medium
- Concentrations:
- 11.25-90 μg/mL
- Details on study design:
- A dose range of 11.25-90 μg/mL was administered to NR8383 alveolar macrophages in cell culture dishes without further addition of protein and the release of lactate dehydrogenase (LDH), glucuronidase (GLU), and tumor necrosis factor α (TNF) was measured after 16 h. Hydrogen peroxide (H2O2) production was assessed after 90 min.
- Conclusions:
- Synthetic amorphous silica (SAS) build up a large class of industrial nanomaterials (NM). Based on their different production processes, precipitated, fumed, gel and colloidal SAS can be distinguished. Previous tests carried out with all four classes of SAS provided by Evonik Resource Efficiency GmbH have demonstrated for most materials a highly similar biological activity (e.g. cytotoxicity or inflammatory potential) on NR8383 alveolar macrophages under serum free-conditions (Wiemann et al 2019). On the other hand, phosphonate coating of a colloidal SAS has been shown to mitigate its bioactivity, both in vitro and in vivo. In this study we tested untreated as well as surface-treated SAS which are mostly relevant for industrial applications.
Five untreated and nine surface treated SAS were tested. While untreated and one surface-treated SAS were dispersed as published before using an ultrasonic dispersion energy of 270 J/mL, strongly hydrophobic surface treated SAS were dispersed according to the NanoGenoTox protocol which requires pre-wetting of the SAS powder with ethanol, followed by an extensive ultrasonic dispersion in H2O in the presence of low serum albumin concentration (0.05% w/v). Further dispersion in cell culture medium had minor effects on agglomeration. A dose range of 11.25-90 μg/mL was administered to NR8383 alveolar macrophages without further addition of protein and the release of lactate dehydrogenase (LDH), glucuronidase (GLU), and tumor necrosis factor α (TNF) was measured after 16 h. Hydrogen peroxide (H2O2) production was assessed after 90 min.
The overall pattern of the in vitro response to untreated SAS was dose-dependent and highly similar to those of the previous study: According to the releases of LDH, GLU cytotoxicity was noted (in decreasing order) for CAB-O-SIL® S17D, CAB-O-SIL® (E)L-90, AEROSIL® 50, LUDOX® TM-50, LUDOX® SM, and AEROSIL® R816. TNF was induced by all untreated SAS. However, CAB-O-SIL® S17D was the only SAS which induce a significant induction of H2O2 release and, like LUDOX® SM and LUDOX® TM-50, evoked a comparatively high TNF response.
In contrast, all these responses were missing for the surface-treated SAS (CAB-O-SIL® TGC413TRD, CAB-O-SIL® TS601, CAB-O-SIL® TS, HDK® H15, HDK® H2000, AEROSIL® R504, AEROSIL® R711, and SIPERNAT® D17) except for the highest concentration of AEROSIL® R504. This striking difference in cytotoxicity between untreated and surface-treated SAS remained when untreated SAS were also dispersed according to the NanoGenoTox protocol, as tested in a pilot experiment.
Overall the study confirms the previously demonstrated high biological activity of untreated SAS under protein free conditions. Importantly, it suggests that the various surface coatings leading to high hydrophobicity abrogate the cytotoxic and pro-inflammatory effect of SAS in vitro under serum-free conditions. - Executive summary:
Overall the study confirms the previously demonstrated high biological activity of untreated SAS under protein free conditions. Importantly, it suggests that the various surface coatings leading to high hydrophobicity abrogate the cytotoxic and pro-inflammatory effect of SAS in vitro under serum-free conditions.
Referenceopen allclose all
The ranges of aerosol concentration, temperature, relative humidity and air flow rate were considered satisfactory for a study of this type. In addition, the test item was considered to be respirable to rats.
Piloerection and wet fur were observed post-exposure in most animals. Piloerection lasted up to day 3 for animals ID1 (male) and ID6 (female). These signs are commonly associated to nose-only exposure studies and may not be correlated to test item. Additionally, loud breathing, loss of stability in females and respiratory crackles in males were observed punctually after exposure. All the signs disappeared after day 2 of the study. These signs are not uncommon in inhalation studies involving very high level of exposure to particles (limit concentration) and as such are not considered as signs of an intrinsic property of the test substance.
From study day 4 until the end of the 14 day-observation period, no clinical signs were observed in any of the animals and all of them exhibited a normal behavior.
A decrease in mean body weight was observed between study day 1 (exposure) and study day 2. This decrease is normally observed in nose-only exposure inhalation studies due to the stress caused by the restraining and the fasting conditions during the exposure period. In general, from study day 2 to the end of the observation period (day 15), body weight increased gradually in all animals.
No necropsy macroscopical findings were observed in animals of any of the sexes exposed to test item.
No clinical symptoms except some restlessness and eye closing. Body weight gain was not affected in males, but females hardly gained weight during two days after exposure, however, subsequently, showed normal development.
No
findings at autopsy after 14 d post-treatment.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- according to guideline
- Guideline:
- other: Guidelines of the Department of Transportation
- Principles of method if other than guideline:
- single dose level, 24h administration, 48h post observation
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- Syloid 244
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- obtained from: Skippack Breeding Farm; app. 3 kg, individually caged, feed: Purina rabbit chow
- Type of coverage:
- occlusive
- Vehicle:
- not specified
- Details on dermal exposure:
- Application to the intact (5 rabbits) and abraded skin (5 rabbits) for 24 h
- Duration of exposure:
- 24 h
- Doses:
- 2 g/kg bw
- No. of animals per sex per dose:
- 10 in total
- Control animals:
- no
- Details on study design:
- Duration of observation period following administration: 48h
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Remarks on result:
- no indication of skin irritation up to the relevant limit dose level
- Sex:
- not specified
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- No changes in skin condition were nited in any animal during the test period.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As there was no mortality, the LD50 in the rabbit was greater 2 g/kg/bw. Also no skin irritation appered, the score (Draize) was 0.0.
- Executive summary:
The acute dermal toxicity if Syloid 244 was assessed in rabbits. Also its skin irritation potential was evaluated.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- single application for 24 hours, on intact and abraded skin, 4 dose levels, 14-day post observation period
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Zeo 49
- Species:
- rabbit
- Strain:
- New Zealand White
- Remarks:
- albino
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Mature healthy New Zealand White albino rabbits were selected from the stock colony. Animals were individually housed in stainless steel suspended cages with Purina Rabbit Chow and water ad libitum.
- Type of coverage:
- occlusive
- Vehicle:
- water
- Remarks:
- distilled
- Details on dermal exposure:
- Rabbits were clipped free of hair over the dorsal area. A single dermal application was employed and test sites were occluded with an impervious bandage for 24 hours.
- Duration of exposure:
- 24 h
- Doses:
- 2000, 3000, 4000, 5000 mg/kg bw
- No. of animals per sex per dose:
- 4 in total per dose: 2 with abraded and 2 with inract skin
- Control animals:
- no
- Details on study design:
- Animals were observed for reactions at 4 hours after dosing, and then daily for 14 days. Body weights were recorded at dosing and at termination. Rabbits sacrificed were subjected to a gross examination of the viscera.
- Preliminary study:
- Four rabbits were clipped free of hair over the dorsal area. A single dermal application at the following levels was employed: 2000, 3000, 4000, and 5000 mg/kg of body weight.
Test sites were occluded with an impervious bandage. After 24 hours, the bandages were removed. The animals were observed for signs of illness or death for up to four days. - Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- not specified
- Dose descriptor:
- LD0
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- Dermal reactions were limited to slight erythema on day 1 in one rabbit with abraded skin treated with 3000 mg/kg bw. The other 15 animals showed no reactions. There was no dose-dependent relationship.
- Body weight:
- All rabbits at all dose levels gained weight.
- Gross pathology:
- Upon necropsy, at day 14, no gross pathology was noted in the viscera.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortality occured, the LD50 of Zeo 49 was greater than 5000 mg/kg bw.
- Executive summary:
Zeo 49 was evaluated for its dermal LD50 in the rabbit. Single applications were made to the intact and abraded skin.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- single application for 24 hours, on intact and abraded skin, 4 dose levels, 14-day post observation period
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Zeofree 153
- Species:
- rabbit
- Strain:
- New Zealand White
- Remarks:
- albino
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Mature healthy New Zealand White albino rabbits were selected from the stock colony. Animals were individually housed in stainless steel suspended cages with Purina Rabbit Chow and water ad libitum.
- Type of coverage:
- occlusive
- Vehicle:
- water
- Remarks:
- destilled
- Details on dermal exposure:
- Rabbits were clipped free of hair over the dorsal area. A single dermal application was employed and test sites were occluded with an impervious bandage for 24 hours.
- Duration of exposure:
- 24 hours
- Doses:
- 2000, 3000, 4000, 5000 mg/kg bw
- No. of animals per sex per dose:
- 4 in total per dose: 2 with abraded and 2 with inract skin
- Control animals:
- no
- Details on study design:
- Animals were observed for reactions at 4 hours after dosing, and then daily for 14 days. Body weights were recorded at dosing and at termination. Rabbits sacrificed were subjected to a gross examination of the viscera.
- Preliminary study:
- Four rabbits were clipped free of hair over the dorsal area. A single dermal application at the following levels was employed: 2000, 3000, 4000, and 5000 mg/kg of body weight.
Test sites were occluded with an impervious bandage. After 24 hours, the bandages were removed. The animals were observed for signs of illness or death for up to four days. - Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- not specified
- Dose descriptor:
- LD0
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- Dermal reactions were limited to slight erythema and edema. Dermal reactions diminished by day 5 after application. They showed no dose-dependent relationship and their duration was in general not longer on abraded skin than on intact one.
- Body weight:
- All rabbits at all dose levels gained weight.
- Gross pathology:
- Upon necropsy, at day 14 no gross pathology was noted in the viscera.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortality occured, the dermal LD50 was greater than 5000 mg/kg of body weight.
- Executive summary:
Zeofree 153 was evaluated for its dermal LD50 in the rabbit. Single applications were made to the intact and abraded skin.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- single application for 24 hours, on intact and abraded skin, 4 dose levels, 14-day post observation period
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Zeosyl 113
- Species:
- rabbit
- Strain:
- New Zealand White
- Remarks:
- albino
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Mature healthy New Zealand White albino rabbits were selected from the stock colony. Animals were individually housed in stainless steel suspended cages with Purina Rabbit Chow and water ad libitum.
- Type of coverage:
- occlusive
- Vehicle:
- water
- Remarks:
- distilled
- Details on dermal exposure:
- Rabbits were clipped free of hair over the dorsal area. A single dermal application was employed and test sites were occluded with an impervious bandage for 24 hours.
- Duration of exposure:
- 24 hours
- Doses:
- 2000, 3000, 4000, 5000 mg/kg bw
- No. of animals per sex per dose:
- 4 in total per dose: 2 with abraded and 2 with inract skin
- Control animals:
- no
- Details on study design:
- Animals were observed for reactions at 4 hours after dosing, and then daily for 14 days. Body weights were recorded at dosing and at termination. Rabbits sacrificed were subjected to a gross examination of the viscera.
- Preliminary study:
- Four rabbits were clipped free of hair over the dorsal area. A single dermal application at the following levels was employed: 2000, 3000, 4000, and 5000 mg/kg of body weight.
Test sites were occluded with an impervious bandage. After 24 hours, the bandages were removed. The animals were observed for signs of illness or death for up to four days. - Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- not specified
- Dose descriptor:
- LD0
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- Dermal reactions were limited to slight erythema, which diminished by day 4 after application. Reactions showed no dose-dependent relationship and dimished only slightly later on abraded skin, than they did on intact one.
- Body weight:
- All rabbits at all dose levels gained weight.
- Gross pathology:
- Upon necropsy, at day 14 no gross pathology was noted in the viscera.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortality occured the dermal LD50 was greater than 5000 mg/kg of body weight.
- Executive summary:
Zeosyl 113 was evaluated for its dermal LD50 in the rabbit. Single applications were made to the intact and abraded skin.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- single application for 24 hours, on intact and abraded skin, 4 dose levels, 14-day post observation period
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Zeosyl 200
- Species:
- rabbit
- Strain:
- New Zealand White
- Remarks:
- albino
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Mature healthy New Zealand White albino rabbits were selected from the stock colony. Animals were individually housed in stainless steel suspended cages with Purina Rabbit Chow and water ad libitum.
- Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- Rabbits were clipped free of hair over the dorsal area. A single dermal application was employed and test sites were occluded with an impervious bandage for 24 hours.
- Duration of exposure:
- 24 hours
- Doses:
- 2000, 3000, 4000, 5000 mg/kg bw
- No. of animals per sex per dose:
- 4 in total per dose: 2 with abraded and 2 with inract skin
- Control animals:
- no
- Details on study design:
- Animals were observed for reactions at 4 hours after dosing, and then daily for 14 days. Body weights were recorded at dosing and at termination. Rabbits sacrificed were subjected to a gross examination of the viscera.
- Preliminary study:
- Four rabbits were clipped free of hair over the dorsal area. A single dermal application at the following levels was employed: 2000, 3000, 4000, and 5000 mg/kg of body weight.
Test sites were occluded with an impervious bandage. After 24 hours, the bandages were removed. The animals were observed for signs of illness or death for up to four days. - Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Sex:
- not specified
- Dose descriptor:
- LD0
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- no mortality
- Clinical signs:
- With 5,000 mg/kg bw, dermal reactions were limited to slight erythema, which diminished after day 2 or 4 after application on intact or abraded skin, repectively. With lesser doses, those were dimished by day 2 after application (on intact and abraded skin).
- Body weight:
- All rabbits at all dose levels gained weight.
- Gross pathology:
- Upon necropsy, at day 14, no gross pathology was noted in the viscera.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- As no mortality occured the dermal LD50 was greater than 5000 mg/kg of body weight.
- Executive summary:
Zeosyl 200 was evaluated for its dermal LD50 in the rabbit. Single applications were made to the intact and abraded skin.
Referenceopen allclose all
No erythema or edema occured. The skin irritation according to the Draize Scoring System was 0.0. (cf. attachement below)
Additional information
Justification for classification or non-classification
Synthetic amorphous silicas did not induce toxicity or lethality by any route of exposure.
According to Annex I of the Regulation (EC) 1272/2008 and GHS (Globally Harmonized Classification System), the test substance requires no classification and has no mandatory label requirement.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.